共 727 条
[61]
Flower D(2014)Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes Breast Cancer Res 16 3764-undefined
[62]
Lopez E(2016)Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer Clin Cancer Res 22 1004-undefined
[63]
Kyle S(2015)Prediction of pathological complete response (pCR) by homologous recombination deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy in patients with TNBC: results from GeparSixto J Clin Oncol 33 1776-undefined
[64]
Meuth M(2012)Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer Br J Cancer 107 5651-undefined
[65]
Curtin NJ(2016)Biomarkers of response and resistance to DNA repair targeted therapies Clin Cancer Res 22 29-undefined
[66]
Helleday T(2011)Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers Cancer Discov 1 210-undefined
[67]
Farmer H(2011)miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors Mol Cell 41 3837-undefined
[68]
McCabe N(2012)Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment Cell Cycle 11 undefined-undefined
[69]
Lord CJ(undefined)undefined undefined undefined undefined-undefined
[70]
Tutt AN(undefined)undefined undefined undefined undefined-undefined